<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../figures/favicon.png" type="image/x-icon">
  <title>Cardiac disease in Pregnancy</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="/style.css">
  <link rel="stylesheet" href="/notes.css">
</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="/index.html">
    <div class="home-navigation">
      M
    </div>
  </a>

  <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="/index.html">Home</a>
      </li>
      <li class="menu__item">
        <a class="menu__link" href="/about-temp2.html">About</a>
      </li>
      
     
      

      <!-- <li class="menu__item">
        <a class="menu__link" href="#0">Projects</a>
        <ul class="submenu">
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Surgery</a>
          </li>
          <li class="menu__item">
            <a class="menu__link" href="/404.html">Pediatrics</a>
          </li>
        </ul>
      </li> -->
    </ul>
  </nav>
  
  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterðŸ’œ</p>
      <span><a href="/contribute.html">Contribute here</a> </span>
    </div>

    <h1>Cardiac disease in Pregnancy</h1>
  
    <!-- <div class="author-flex">
      <div class="author-img">
        <img  src="/contributors/vt1.jpeg" alt="">
      </div>
      <div>
        <h2 class="name">Compiled by Victortayo</h2>
        <p class="updated">last updated, Nov 2022</p>
      </div>
    </div> -->

    <article class="notes">
        <a id='top'></a>
    <article>
    <!-- <h2 class='title'>Outline</h2> -->
    <label class="trigger outline">
        <input type="checkbox" class="checkbox checkbox--red" /> Show/hide outline
        <div class="msg">
         <ol>
            <li><a href="#header-1">Introduction</a></li>
            <li><a href="#header-2">Etiology</a></li>
            <li><a href="#header-3">Physiologic changes in pregnancy</a></li>
            <li><a href="#header-4">Pathological CVS features</a></li>
            <li><a href="#header-5">Physiological changes during labor and puerperium</a></li>
            <li><a href="#header-6">Prognosis</a></li>
            <li><a href="#header-7">The indications for Termination of pregnancy</a></li>
            <li><a href="#header-8">Risk factors for cardiac failure during pregnancy</a></li>
            <li><a href="#header-9">Management areas </a></li>
         </ol>
        </div>
      </label>

      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Introduction</a>
          </h2>
        </header>
        <div class='body'>
            <p>It is estimated that 1% to 3% of women either have cardiac disease entering pregnancy or are diagnosed with cardiac disease while they are pregnant. </p>
            <p>The frequency of specific types depends on the patient population and local conditions.</p>
        </div>

      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Etiology</a>
          </h2>
        </header>
        <div class='body'>
            <p>Previously, Rheumatic heart disease caused about 90% of all cardiac disorders encountered in pregnancy. </p>
            <p>This occurred as a result of abnormal reaction to a streptococcal infection (Rheumatic fever) which subsequently caused autoimmune damage to the heart valves.</p>
            <p> Rheumatic heart disease now accounts for 40-50%</p>
            <p>Congenital cardiac defects account for about 50% </p>
            <p>Other causes include hypertensive heart disease, cardiomyopathies e.g. which account for about 10%</p>

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Physiologic changes in pregnancy</a>
          </h2>
        </header>
        <div class='body'>
            <p>In normal pregnancy blood volume begins to increase in the first trimester to peak at 32/34 weeks gestation by 30% to 50% of pre pregnancy level. There is a corresponding increase in Cardiac output.</p>
            <p>Cardiac Output (CO) = Stroke Volume x Heart Rate</p>
            <p>Blood pressure = Cardiac Output x Peripheral resistance</p>

            <h4><span class="special-text-4">Causes of increased cardiac output (CO) are </span></h4>
            <ol>
                <li>Increase in stroke volume (early pregnancy) </li>
                <li>Increase in heart rate (late pregnancy) </li>
                <li>Decreased peripheral resistance</li>
                <li>Decreased blood viscosity</li>
            </ol>
            <p>This increase in CO is correspondingly affected by number of fetus and more in twins and higher order gestation. </p>

            <h4><span class="special-text-4">Blood Pressure </span></h4>
            <p>Blood pressure = Cardiac Output x Peripheral resistance</p>
            <p>Remains almost at pre-pregnant levels in first trimester with a tendency to fall during particularly during mid-trimester as the systemic vascular/peripheral resistance falls significantly.  </p>
            <p>The fall in the peripheral resistance is about 20-30% at 21-24 weeks & returns to normal at term. This fall is due to </p>
            <ul>
                <li>Trophoblastic erosion of endometrial vessels, the placental bed serves as a large arteriovenous shunt causing lowered systemic vascular resistance</li>
                <li>Physiological vasodilatation which is believed to be secondary to endothelial prostacyclin and circulating progesterone.</li>
            </ul>

            <h4><span class="special-text-4">Colloid oncotic pressure </span></h4>
            <p>This is another important variable</p>
            <p>Both plasma and interstitial colloid oncotic pressure decrease (relative dilution of proteins) throughout pregnancy.</p>
            <p>There is accompanying increase in capillary hydrostatic pressure (due to increase fluid volume).</p>
            <p>An increase in capillary hydrostatic pressure or a decrease in colloid oncotic pressure may be forcing water out of the circulatory system and causing edema formation.</p>
            <p>Sometimes a balance may be obtained because of the decrease in the interstitial oncotic pressure. </p>
            <p>After delivery, decrease in plasma colloid oncotic pressure worsens reaching a peak between 6 to 16 hours and returns towards intrapartum level after 24 hours. </p>
            <p>These changes can lead to dependant edema complicating diagnosis of cardiac decompensation.</p>

            <figure>
                <img src="" alt="">
                <figcaption> 
                    Summary of CVS changes in pregnancy
                    <ul>
                        <li>CVP: Central venous pressure</li>
                        <li>SVR:  Systemic vascular resistance</li>
                        <li>PVR: Pulmonary vascular resistance</li>
                    </ul> 
                </figcaption>
            </figure>

            <figure>
                <img src="" alt="">
                <figcaption>Misleading features during pregnancy </figcaption>
            </figure>

            <p>The clinical features in a normal pregnancy which can mimic a cardiac disease are </p>
            <ol>
                <li>Dyspnea - due to hyperventilation, elevated diaphragm</li>
                <li>Pedal edema </li>
                <li>Cardiac impulse- Diffused and shifted laterally from elevated diaphragm.</li>
                <li>Jugular veins may be distended and JVP raised.</li>
                <li>Systolic ejection murmurs along the left sternal border occur in 96% of pregnant women and are believed to be caused by increased flow across the aortic and pulmonary valves.  </li>
            </ol>
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Pathological CVS features</a>
          </h2>
        </header>
        <div class='body'>
            <p>Criteria to diagnose cardiac disease during pregnancy:</p>
            <ol>
                <li>Presence of diastolic murmurs.</li>
                <li>Systolic murmurs of severe intensity (grade 3).</li>
                <li>Unequivocal enlargement of heart (X-ray).</li>
                <li>Presence of severe arrhythmias, atrial fibrillation or flutter </li>
            </ol>
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Physiological changes during labor and puerperium</a>
          </h2>
        </header>
        <div class='body'>
            <p>First stage:  Cardiac output increases by 15%. Uterine contractions increases venous return, causing increase in cardiac output & can cause reflex bradycardia.</p>
            <p>Second stage: Increase in intra-abdominal pressure (valsalvaâ€™s) causes decrease in venous return and cardiac output.</p>
            <p>Third stage: Normal blood loss during delivery (around 250-350 ml). It leads to</p>
            <ol>
                <li>Decrease blood volume</li>
                <li>Decrease cardiac output</li>
            </ol>

            <figure>
                <img src="" alt="">
                <figcaption>The New York Heart Association (NYHA) grading of functional capacity of the heart </figcaption>
            </figure>
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Prognosis</a>
          </h2>
        </header>
        <div class='body'>
           <p>Prognosis depends on the functional status</p>
           <p>In general, women in NYHA classes I and II lesions usually do well during pregnancy and have a favorable prognosis with a mortality rate of <1%. </p>
           <p>Patients in NYHA classes III and IV may have a mortality rate of 5% to 15%. These patients should be advised against becoming pregnant. </p>
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'> The indications for Termination of pregnancy</a>
          </h2>
        </header>
        <div class='body'>
           <p> Because of high maternal risks, MTP is indicated in:</p>
           <ol>
            <li>Eisenmengerâ€™s syndrome.</li>
            <li>Marfanâ€™s syndrome with aortic involvement</li>
            <li>Pulmonary hypertension.</li>
            <li>Coarctation of aorta with valvular involvement. </li>
           </ol>
           <p>Termination should be done before 12 weeks of pregnancy.</p>
           <p>Eisenmengerâ€™s Syndrome: Increased pulmonary flow (Lâ†’R shunt due to ASD, VSD or PDA) causes hypertrophy of pulmonary arteriesâ†’ pulmonary hypertensionâ†’ reversal of shunt to Râ†’L with cyanosis.</p>
           <ul>
            <li>Need to correct Lâ†’R shunt BEFORE it reverses.</li>
            <li>Need to correct Lâ†’R shunt despite normal ABGs.</li>
           </ul>
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'>Risk factors for cardiac failure during pregnancy </a>
          </h2>
        </header>
        <div class='body'>
           <ul>
            <li>Infection</li>
            <li>Anemia</li>
            <li>Obesity </li>
            <li>Hypertension </li>
            <li>Hyperthyroidism</li>
            <li>Multiple pregnancy</li>
           </ul>
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'>Management areas  </a>
          </h2>
        </header>
        <div class='body'>
           <p>Areas be considered in the clinical approach to the woman with heart disease who is pregnant or considering pregnancy: </p>
           <ol>
            <li>Pre-conceptional - Risk stratification</li>
            <li>Ante-partum management </li>
            <li>Peri-partum management</li>
           </ol>

           <h4><span class="special-text-4">Pre-conceptional counselling </span></h4>
           <p>This is an important aspect of management of the cardiac patient planning a pregnancy. </p>
           <p>Ideally, the obstetrician and cardiologist should work together to help the patient make an informed decision. </p>
           <p>Prevent an unwanted pregnancy and avoid the risks associated with pregnancy continuation or termination. </p>

           <h4><span class="special-text-4">Antepartum care</span></h4>
           <p>The chief aim of management of the patient in pregnancy is to keep patient within her cardiac reserve. </p>
           <p>Ionotropic and chronotropic management of heart</p>
           <p>Management of arrhythmias, tachyarrhythmia, flutters and fibrillations</p>
           <p>Anticoagulants</p>
           <p>Problems should be identified early and treated aggressively, especially pregnancy induced hypertension, hyperthyroidism, infection, and anemia.</p>
           <p>Limit activity especially in women with ventricular dysfunction, left heart obstruction, or class III or IV symptoms.</p>
           <p>Hospital admission by mid-second trimester may be advisable for some.</p>
           <p>Beta-blockers rather than digoxin should be used to control the heart rate for patients with functionally significant mitral stenosis.</p>
           <p>Sustained tachyarrhythmias, such as atrial flutter or atrial fibrillation, should be treated promptly.</p>
           <p>If possible, all antiarrhythmic drugs should be avoided during the first trimester, and those known to be teratogenic should be avoided throughout pregnancy.</p>
           <p>Because of their safety profiles, preferred drugs include digoxin, beta-blockers and adenosine.</p>

           <h4><span class="special-text-4b"> Anticoagulation therapy</span></h4>
           <p>Oral therapy with warfarin is effective and logistically easy. </p>
           <p>However, it can affect embryonic organ development, although some evidence shows that a dosage of 5 mg per day may not be teratogenic.</p>
           <p> Fetal intracranial bleeding is a risk throughout pregnancy, particularly during vaginal delivery, unless warfarin is stopped before labor.</p>
           <p>Warfarin use in first trimester can be teratogenic and can cause fetal embryopathy (15 to 25 %) which includes: </p>
           <ul>
            <li>Nasal cartilage hypoplasia, </li>
            <li>Stippling of bones (focal bone calcification or multiple ossification centers that severely deform the bone).</li>
            <li>IUGR and </li>
            <li>Brachydactyly (shortening of the fingers and toes due to unusually short bones).</li>
           </ul>
           <p>Heparin in adjusted subcutaneous doses does not cross the placenta and so has no teratogenic effects. </p>
           <p>However, it may cause maternal thrombocytopenia and osteoporosis and is less effective in preventing thrombosis in patients with prosthetic valves.</p>
           <p>More recent guidelines recommend either</p>
           <ol>
            <li>Adjusted-dose heparin during the entire pregnancy or</li>
            <li>Adjusted-dose heparin until the 13th week of gestation, </li>
            <ul>
              <li>Warfarin from the 14th week to the middle of the third </li>
              <li>Trimester, and then restart adjusted-dose heparin.</li>
              <li>Low-molecular-weight heparin in adjusted</li>
              <li>Doses is easier to administer and has been</li>
              <li>Suggested as an alternative to adjusted-dose</li>
              <li>Unfractionated heparin. </li>
            </ul>
           </ol>
           
           <h4><span class="special-text-4b">Antibiotic prophylaxis</span></h4>
           <h4>High-risk patient </h4>
           <p>Penicillin or Cephalosporin IM or IV, plus Gentamicin, 1.5 mg/kg IV 30 min before procedure;  </p>

           <h4>High-risk patient with penicillin allergy </h4>
           <p>Vancomycin 1 g IV over 2 hr plus Gentamicin, 1.5 mg/kg IV 30 min before procedure </p>

           <h4><span class="special-text-4">Peripartum/intrapartum care</span></h4>
           <p>Vaginal delivery generally preferred. Hemodynamic changes less with vaginal delivery. </p>
           <p> Caesarean section only when indicated</p>
           <p>Positioning the patient on her left side lessens the hemodynamic fluctuations associated with contractions when the patient is supine.</p>
           <p>Cardiotocographic monitoring of fetal heart and maternal contractions.</p>
           <p>Intermittent or continuous oxygen</p>
           <p>Effective alleviation of pain, epidural recommended as it also reduces cardiac output by causing peripheral vasodilatation.</p>
           <p>Forceps or vacuum extraction should be considered at the end of the second stage of labor to shorten 2nd and ease delivery.</p>
           <p>Avoid use of ergometrine as it causes vasoconstriction and syntocinon can cause vasodilation and fluid retention.</p>

           <h4><span class="special-text-4b">Fluid changes</span></h4>
           <p>In the third stage up to a liter of blood may be returned to the circulation due to the relief of inferior vena cava obstruction  </p>
           <p>Autotransfusion from the contracted and retracted emptied uterus</p>
           <p>The intrathoracic and cardiac blood volume rise</p>
           <p>Cardiac output increases by 60â€“80% </p>
           <p>Followed by a rapid decline to prelabour values within about 1 hour of delivery.</p>
           <p>Transfer of fluid from the extravascular space increases venous return and stroke volume further. </p>
           <p>Those women with cardiovascular compromise are therefore most at risk of pulmonary edema during the second stage of labor and the immediate post-partum period</p>

           <h4><span class="special-text-4">Postpartum care</span></h4>
           <p>Lactation should be encouraged unless patient is in failure.</p>
           <p> Cardiac output is not compromised during lactation. </p>
           <p>Lactation is a pathway for fluid excretion and diuretic requirement may actually fall.</p>

           <h4><span class="special-text-4b">Contraception</span></h4>
           <p>Barrier methods â€“ unreliable. Have high failure rates</p>
           <p>COC contraindicated. They can cause thromboembolism.</p>
           <p> IUCD can cause infection- endocarditis.</p>
           <p>Progesterone only pill have better side effect profile & long acting slow releasing as Mirena intrauterine system have improved efficacy.</p>
           <p>Sterilization where family completed (Laparoscopic clip sterilization carries risk). </p>

        </div>
      </section>

      </section>

      <div class="contact">
        <hr style="margin: 3rem 0;">

        <p>Send us a <a href="mailto:obgyn.materia@gmail.com"><span class="special-text-2">mail</span></a> at 
         <br> obgyn.materia@gmail.com.</p>
        <p>Or send your comments, corrections, explanations/clarifications and requests/suggestions to our 
         <br> <a href="" class="special-text-2" style="text-decoration: none;">WhatsApp group</a>.</p>
      </div>
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p>obgyn.materia</p>
          
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="/main.js"></script>
</body>
</html>
 
